| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |